In Brief: FDA botanical drugs guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA botanical drugs guidance: In the final stages of development, guidance will cover clinical studies in botanical ingredients being developed for prescription or OTC drug use. The document will delineate the compounds and include sections on chemistry/manufacturing controls, preclinical requirements and clinical trials. The agency is targeting this fall for the guidance's release...